SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced more than 65 presentations reporting on investigational studies in blood and solid tumor cancers will be presented during the 52ndAmerican Society of Clinical Oncology meeting in Chicago, Ill. from June 3-7, 2016.
